Patents Assigned to ALBERT EINSTEIN COLLGE OF MEDICINE, INC.
  • Publication number: 20190240321
    Abstract: Methods for passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such.
    Type: Application
    Filed: January 3, 2019
    Publication date: August 8, 2019
    Applicant: ALBERT EINSTEIN COLLGE OF MEDICINE, INC.
    Inventor: Betsy Herold
  • Publication number: 20190111127
    Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.
    Type: Application
    Filed: June 1, 2018
    Publication date: April 18, 2019
    Applicant: ALBERT EINSTEIN COLLGE OF MEDICINE, INC.
    Inventors: William Jacobs, JR., Pablo A. Gonzalez-Munoz, Betsy Herold, Christopher Petro
  • Publication number: 20190010234
    Abstract: Provided are methods of treating an autoimmune disease in a subject, or of suppressing transplant rejection in a subject, or of treating a cancer in a subject, as well as compositions therefor.
    Type: Application
    Filed: September 5, 2018
    Publication date: January 10, 2019
    Applicant: ALBERT EINSTEIN COLLGE OF MEDICINE, INC.
    Inventor: Xingxing Zang
  • Publication number: 20180369281
    Abstract: A method of reducing a cerebral tissue pathology associated with a sickle cell disease therapy in a subject is provided using (i) a synthetic high-oxygen affinity hemoglobin-containing molecule or (ii) synthetically treated high-oxygen affinity blood.
    Type: Application
    Filed: November 8, 2016
    Publication date: December 27, 2018
    Applicant: ALBERT EINSTEIN COLLGE OF MEDICINE, INC.
    Inventors: Craig Branch, Seetharama Acharya
  • Publication number: 20180201935
    Abstract: Methods of treating a wound in a subject are provided comprising administering to the subject an amount of an inhibitor of Fidgetin-like 2. Compositions and pharmaceutical compositions comprising an amount of an inhibitor of Fidgetin-like 2 are also provided. Methods are also provided for identifying an inhibitor of Fidgetin-like 2.
    Type: Application
    Filed: March 12, 2018
    Publication date: July 19, 2018
    Applicant: ALBERT EINSTEIN COLLGE OF MEDICINE, INC.
    Inventors: David J. Sharp, Rabab Charafeddine